Device Reform Bill’s Future Murky; PDUFA Inclusion Unlikely, Members Say
This article was originally published in The Gray Sheet
Executive Summary
A letter to key congressional leaders from several medical device trade associations appears to be a last-ditch effort by the industry to urge the inclusion of medical device reform provisions in legislation reauthorizing the Prescription Drug User Fee Act
You may also be interested in...
Combination Product Regulation Will Come Under Scrutiny At May 1 Meeting
AdvaMed members will have an opportunity to voice concerns over combination product regulation at a May 1 meeting with FDA Combination Products Program Director Mark Kramer
Combination Product Regulation Will Come Under Scrutiny At May 1 Meeting
AdvaMed members will have an opportunity to voice concerns over combination product regulation at a May 1 meeting with FDA Combination Products Program Director Mark Kramer
Tauzin Will Tackle Device Reforms Outside PDUFA; Eshoo Urges Hearings
House Energy & Commerce Committee Chairman Billy Tauzin (R-La.) will work with medical device reform bill sponsors to move HR 3580 independently of Prescription Drug User Fee Act reauthorization